Table 2.
Blood lipids and apolipoproteins concentrations before and after intervention.
| (mg/dL) | CG | EG | Week 12–Week 0 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Week 0 | Week 12 | Week 0 | Week 12 | CG | EG | CI 95% | ||||
| TC | 201.80 ± 40.41 | 197.16 ± 36.95 | 195.39 ± 37.38 | 201.46 ± 38.81 | −2 (−90; 43) | 6.5 (−24; 50) | 10.72 (0.37; 22.74) | # | ||
| HDL-C | 54.97 ± 16.47 | * | 53.97 ± 11.08 | 47.89 ± 8.00 | * | 52.00 ± 9.24 | 2 (−48; 12) | 4.5 (−5; 16) | 5.11 (1.96; 11.46) | # |
| LDL-C | 128.97 ± 31.34 | 125.61 ± 29.29 | 127.32 ± 32.45 | 129.71 ± 31.59 | 3 (−11; 16) | 2.5 (−9; 31) | 1.39 (−2.15; 5.92) | |||
| TAG | 89.00 ± 42.24 | 87.81 ± 47.65 | 100.71 ± 34.33 | 99.50 ± 31.59 | 6 (−65; 75) | 1 (−56; 53) | −0.02 (−12.8; 14.62) | |||
| ApoA1 | 161.32 ± 26.62 | 153.94 ± 20.85 | 150.68 ± 16.30 | 152.14 ± 18.40 | −1 (−28; 9.6) | 0.3 (−9.8; 24) | 2.74 (−0.3; 6.98) | |||
| ApoB | 102.42 ± 21.45 | 101.65 ± 22.06 | 102.86 ± 23.33 | 108.00 ± 26.20 | −2* (−19; 27) | 3.5* (−20; 34) | 5.92 (0.81; 11.77) | |||
| Glucose | 93.06 ± 8.08 | 95.39 ± 8.49 | 90.82 ± 9.40 | 94.54 ± 7.54 | 2.32 (70.04; 94.06) | 3.71 (67.05; 95.04) | 0.05 (–0.1; 0.19) | |||
Data are expressed as the means ± SDs. Statistical analysis was assessed by Mann–Whitney U test. * Significant difference between groups at week 0 p < 0.05. # Significant difference between groups at the end of the intervention period (week 0–week 12) p < 0.05. Abbreviations: TC: total cholesterol; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; and TAG triglycerides.